|
|
 |
|
CIBA Vision
|
Ciba vision is a company that researches, develops, and manufactures contact lenses and their accompanying lens products.
Founded in 1859, Cibavision has since merged with Sandoz to form Norvartis- thus- being known as a Norvartis company. Ciba vision manufactures contact lenses- most notably Air Optix brand- that are designed to ease the hassle of lens wearing while also promoting unmatched comfort and health. Their Tricomfort technology ensures that your lenses will, retain moisture, allow your eyes to breath, and resist deposit. Your eyes will look as healthy as they feel.
Cibavision is notable for the massive steps in innovation they’ve taken to enhance the quality of contact lenses as a whole. They’ve developed the first disposable contact lens, one of the best lenses for astigmatism, and even manufactured a lens that is suitable for 30 days of continuous wear. To go along with their lenses, the company has manufactured lens care solutions that even further the comfort and functionality of the lenses. AOsept Plus Cleaning & Disinfecting Solution remains one of the top brands optometrists suggest for lens care. To ensure effective and healthy wear, Cibavision even features a proper use and care guide on their site- they want to ensure your eyes are taken care of.
Ciba vision remains one of the top lens care providers, not only nationally, but globally- their products are available in over 70 different countries. Their innovative products help to shape our vision of the future. Intrinsically motivated by our needs- and our eyes- Ciba vision will continue to lead the stride into the future. Unparalleled service. Unselfish Commitment. Unmatched Innovation. Outstanding products. Ciba vision is truly the whole package.
|
|
Please choose the following products of CIBA Vision
|
|
|
|
|
Page:1 2 3 4 5 6 7 8 9 |
|
|
|
Today's News about CIBA Vision |
Research and Markets: The Global Vision Care Devices Market is Expected to Grow at a CAGR of 4.4% from 2010 - 2017
Research and Markets has announced the addition of GlobalData's new report "Vision Care Devices - Global Pipel
Mimetogen Pharmaceuticals Inc. Appoints Kim Brazzell, Ph.D. as Chief Medical Officer
Mimetogen Pharmaceuticals Inc. today announced that it has appointed ophthalmic industry veteran Kim Brazzell, Ph.D. as Chief Medical Officer. Dr. Brazzell will lead the development of Mimetogen’s MIM-D3 pivotal program for the treatment of dry eye.
Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK , Jan. 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Vision Care Devices - Global Pipeline Analysis, Competitive Landscape ...
Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011
Fourth quarter sales rose 5% while core[1] operating income grew 17% in constant currencies (cc); full year sales up 12% cc and core operating income up 16% cc Net sales increased 4% (+5% cc) to USD 14.8 ...
With online buyers growing, niche sites mushroom
Niche e-commerce sites, catering to a single product-vertical, are fast catching on.
CDISC Announces New Board Members and Chief Technology Officer
CDISC ushers in the New Year with changes to its leadership. The addition of three highly qualified individuals to its board of directors will bring invaluable expertise to the CDISC organization for the term 2012 - 2015. Returning to the Board are Dr. C. David Hardison, and Dr. Pierre-Yves Lastic, joined by new board member Mr. Robert Goodwin. Each brings a unique skillset to the BoD to help ...
Novartis Is Open to Deals of as Much as $3 Billion, CEO Jimenez Says
Novartis AG (NOVN) Chief Executive Officer Joseph Jimenez said the drugmaker is open to “bolt-on” deals of $2 billion to $3 billion this year as it seeks to expand its product offerings and grow in businesses such as animal health.
Clearside Biomedical Launches $4 Million Share Offering - cbl
By Bill MurphySUWANEE, Ga. -- Clearside Biomedical Inc. has raised $1.20 million, or 30 percent...
Breakthrough in Duration of Continuous Monitoring Action in Type 1 Diabetics
EyeSense AG today announced positive results from a Clinical study involving Type I Diabetic patients conducted at Heidelberg University in Germany that mark a key milestone in the Company’s efforts to revolutionize Glucose testing through the use of its highly proprietary photometric sensor technology.Basel, Switzerland / Grossostheim, Germany (PRWEB) February 02, 2012 Three fold Increase in ...
ING DIRECT Receives Prestigious Contact Center Employer of Choice(R) Certification Award in 2011
TORONTO, ONTARIO--(Marketwire - Jan. 30, 2012) - CCEOC Inc. announced today that ING DIRECT Canada Sales and Service have achieved the Gold level Contact Center Employer of Choice® (CCEOC) designation.
|
|
